dystrophy, which are often mitotically unstable and result in diffuse smears on Southern transfers, HD alleles exhibit little if any mitotic instability.
Thus, the expanded alleles in HD always appear sharp and just as intense as the normal alleles.
The direct measurement of the CAG repeat in the HD gene is a sensitive and highly accurate molecular diagnostic test. Although linkage testing has been available for HD families for several years, the linkage testing is more expensive and less accurate, especially when key family members are unavailable. The described Southern protocol has provided us with an additional confirmation of the PCR results. We have found excellent agreement between the results of the two types of mutational analyses. The Southern test has been particularly useful when dealing with affected patients with highly expanded alleles (>70 repeats), which often fail to amplify well, and nonaffected patients who are homozygous for normal-size alleles. Use of the Southern test also represents an excellent quality-assurance step, which is particularly important in the presymptomatic cases. Given the seriousness of the diagnosis and the clinical variability of HD, all efforts should be made to reduce the possibility of a misdiagnosis. All results in our laboratory have been generated by two independent types of DNA tests, thus reducing the chance of error. Oxidative stress, the potential for tissue damage from an excess of free radical production over available antioxidant defenses, [1] is now incriminated in >100 disease states [2] . Although individual antioxidant moieties play specific roles in combatting oxidative stress, the physiological concentrations and effects of each antioxidant
should not be interpreted in isolation [3] . In recent years, several methodologies designed to measure the total antioxidant status of body fluids with a view to diagnostic and (or) prognostic use in humans have been described [4] .
The most widely used of these methods, the total (peroxyl) radical-trapping antioxidant potential (TRAP) assay [5] , is unfortunately too lengthy to permit the analysis of large batches of samples and is also technically difficult, requiring specialized equipment.
A more recent technique [4, 6] measures the ability of antioxidants within physiological fluids to quench the absorbance of the radical cation formed by the reaction of 2,2'-azmnobis-(3-ethylbenzothiazolmne-6-sulfonic acid) (ABTS) with a peroxidase and hydrogen peroxide. This method is suitable for automation with a centrifugal analyzer and thus permits rapid throughput of samples. The assay is now available as a "Total Antioxidant Status" kit (Randox Labs., Crumlin, UK). The kit has recently been used to monitor possible changes in serum total antioxidant status after consumption of red wine [7] . these results raised grave doubts as to the accuracy of any quantitative measure of total antioxidant capacity using this assay. Consequently, further studies using individual antioxidants were undertaken to attempt to pinpoint the source of the problems.
It is known that albumin, urate, and ascorbate make the major contributions to the total antioxidant capacity of human plasma [6], largely because of their high concentrations relative to those of other blood antioxidants such as bilirubin, a-tocopherol, and (3-carotene.
Albumin fraction V (bovine; Sigma, Poole, UK), uric acid (Sigma), and ascorbic acid (Merck, Lutterworth, UK) were therefore prepared as calibrators, in the concentration range 0-2 mmol/L for comparison with Trolox. Figure 1 summarizes the time course of ABTS production, as monitored by absorbance at 600 nm, in the presence of each of these substances, together with the profiles for plasma and a "blank" reaction, for comparison. Ascorbate behaves in an analogous manner to Trolox, showing a lag phase during which no color is generated, followed by a rapid production of ABTS.
The TEAC value for ascorbate derived from these data (0.95) is independent of run time, and suggests that ascorbate, like Trolox, acts as a sacrificial antioxidant in that no ABTS is observed until the antioxidant is consumed.
However, the kinetics for albumin are entirely different. No lag phase is observed, but the rate of color development is lower than that for the blank reaction, Trolox, or ascorbate. These data suggest that albumin reacts slowly to quench ABTS' after Time (s) its formation and (or) inhibits the peroxidase-catalyzed reaction generating the chromophore. Albumin therefore mimics plasma in that it apparently becomes a more efficient antioxidant as incubation time increases, the TEAC value rising from 0.24 at 2 mm to 0.47 at 3 mm. Furthermore, the reaction mixture for cuvettes containing albumin ultimately turns pale purple, as for plasma.
Urate displays a reaction profile showing mixed characteristics; a lag phase during which absorbance increases little, followed by a "slow" generation of the radical cation. The TEAC therefore again rises with increasing run time.
In summary, these three key antioxidants of plasma apparently influence ABTS' production by differing mechanisms, because the kinetics of chromophore generation vary markedly. It is a key requirement of any technique purporting to measure "total antioxidant capacity" that all antioxidants contributing to this capacity behave in an analogous manner. This requirement is clearly not met for this "Total Antioxidant Status" kit; thus, any results obtained must be regarded as, at best, semiquantitative because they are critically dependent on the analyzer parameters used. In particular, attempts to correlate the contributions of individual antioxidants with the measured total antioxidant capacity are doomed to failure. We recommend that in validating any novel methodology for total antioxidant status, close attention be paid to confirming that the kinetics of reaction are equivalent for all the key physiological antioxidants, thereby ensuring that the measured antioxidant capacity is essentially independent of the precise assay conditions selected. Furthermore, our interest in a clinical setting is to monitor changes in blood antioxidant status after supplementation with micronutrient antioxidants. As noted by others [5, 6, 9] , the major contributions to total antioxidant status are provided by albumin and urate, rather than micronutrients such as ascorbate and a-tocopherol.
Total antioxidant capacity is raised in the serum of patients predialysis, substantially because of high serum urate, despite low ascorbate [9] . The fall after dialysis is Technical Briefs largely due to reduced urate concentrations, although protein thiols rise [9] . Thus, despite an apparently normal total antioxidant capacity in a patient, the monitoring of individual micronutrient antioxidants, each of which may play key roles, remains essential.
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